ACE2 and COVID-19: Imbalanced ACE/ACE2 and RAAS activation are responsible, at least in part, for COVID-19 progression which can lead to cardiac damage by inducing a hyperinflammatory response characterized by high levels of IL-6, IL-1, and TNF-α [312].